Kindred Biosciences Announces Positive Opinion from CVMP in the European Union for Mirataz® (mirtazapine transdermal ointment) for Cats Experiencing Poor Appetite and Weight Loss

October 10, 2019

- Mirataz would be the first and only medication approved in the EU to treat cats...

Kindred Biosciences Secures $50 Million Debt Facility with Solar Capital Partners

October 2, 2019

  SAN FRANCISCO , Oct. 2, 2019 /PRNewswire/ --  Kindred Biosciences, Inc. (Nasdaq...

Kindred Biosciences Awarded a Contract by the National Cancer Institute in Support of the PREVENT Cancer Program

September 10, 2019

SAN FRANCISCO , Sept. 10, 2019 /PRNewswire/ --  Kindred Biosciences, Inc. (NASDAQ...